Chemed officer proposes sale of 2,000 shares
CHEMED CORP (CHE) is identified as issuer in a proposed sale for Kevin J. McNamara, identified as an officer: 2,000 common shares, with an aggregate market value of $998,000 and an approximate sale date of September 18, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CHEMED CORP (CHE) is identified as issuer in a proposed sale for Kevin J. McNamara, identified as an officer: 2,000 common shares, with an aggregate market value of $998,000 and an approximate sale date of September 18, 2026. Raymond James & Associates, Inc. is listed as broker. Two prior sales are listed under the name Kevin K. McNamara: 2,000 shares on August 21, 2026, for $1,082,324 in gross proceeds, and 2,000 shares on August 3, 2026, for $1,079,023 in gross proceeds.
Key Figures
Key Terms
Rule 144 regulatory
attorney-in-fact technical
Stock Award financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.